COVID-19 Vaccination in Pregnancy: Efficacy of Second-Generation Vaccines, Maternal-Neonatal Safety, and Strategies to Address Vaccine Hesitancy - Summary - MDSpire
Advertisement
COVID-19 Vaccination in Pregnancy: Efficacy of Second-Generation Vaccines, Maternal-Neonatal Safety, and Strategies to Address Vaccine Hesitancy
To evaluate current vaccination strategies for pregnant women using second-generation COVID-19 vaccines, focusing on their effectiveness and safety, and analyze barriers to vaccine uptake.
Key Findings:
Pregnant women are at increased risk for severe COVID-19 outcomes, including ICU admission and maternal mortality, particularly with the Omicron variant.
Physiological changes during pregnancy can worsen respiratory function in infected individuals.
Robust evidence supports the efficacy and safety of COVID-19 vaccines, yet vaccine hesitancy persists.
Interpretation:
The review underscores the need for further research to refine vaccination protocols, address vaccine hesitancy, and support equitable access to vaccines for pregnant women.
Limitations:
The review highlights ongoing concerns about potential adverse effects and fetal safety that contribute to vaccine hesitancy, and may not cover all demographic factors influencing this hesitancy.
Conclusion:
Further research is necessary to ensure the safe and effective deployment of COVID-19 vaccines during pregnancy.
